Latest in News & Research
Is Tirbanibulin Effective for Treating Actinic Keratosis?
Improvement seen in Skindex-16 quality-of-life scores in symptoms, emotions, functioning domains at week 8 with tirbanibulin
By Dermsquared Editorial Team | May 24, 2023
Do Patients With Melasma Have Lower Levels of Serum Vitamin D?
Average serum calcidiol 33.8 ± 15.8 ng/mL seen in patients with melasma versus 36.8 ± 15.8 ng/mL in other dermatology patients
By Dermsquared Editorial Team | May 24, 2023
Microdosed Incisional Clindamycin Cuts SSI After Skin Cancer Surgery
Significantly fewer lesions receiving microdosed clindamycin, flucloxacillin required postoperative systemic antibiotics
By Elana Gotkine (HealthDay News) | May 24, 2023
JYNNEOS Vaccine Seems Effective for Preventing Mpox
Two-dose series offers better protection, with vaccine effectiveness of 66.0 percent compared with 35.8 percent for one-dose
By Elana Gotkine (HealthDay News) | May 19, 2023
Is Oxymetazoline Effective for Persistent Facial Erythema of Rosacea?
Clinician Erythema Assessment success rate significantly higher after oxymetazoline treatment versus vehicle
By Dermsquared Editorial Team | May 19, 2023
Hyaluronic Acid-Based Filler Produces Midface Volume Restoration
Benefit persists for 540 days in some individuals, even without retouch
By Dermsquared Editorial Team | May 19, 2023
Domestic Abuse Tied to Higher Risk for New Atopic Disease
Higher risk seen for asthma, atopic eczema, and allergic rhinoconjunctivitis
By Lori Solomon (HealthDay News) | May 19, 2023
Brepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis
Significantly greater ACR20 response rates seen at week 16 for 30 and 60 mg QD versus placebo; response maintained or improved at 52 weeks
By Elana Gotkine (HealthDay News) | May 18, 2023
CDC Warns That Mpox Could Make a Summer Return
An outbreak in Chicago of the virus formerly called monkeypox has public health officials on edge
By HealthDay News | May 16, 2023
People With Alopecia Have Higher Risk for Inflammatory Arthritis
Increased risk seen for psoriatic and rheumatoid arthritis, and ankylosing spondylitis
By Lori Solomon (HealthDay News) | May 15, 2023
Skin Lesions Often First Sign of Mpox Infection in 2022 Outbreak
39 percent of patients had fewer than five lesions; papules, vesicles, pustules predominated in first five days of infection
By Dermsquared Editorial Team | May 10, 2023
Dupilumab Beneficial for Adults With Prurigo Nodularis
All primary and key secondary end points met in two phase 3 trials of adults with PN with ≥20 nodules
By Elana Gotkine (HealthDay News) | May 10, 2023
Mindfulness, Self-Compassion Training Improves QOL in Eczema
Intervention group showed greater improvement in Dermatology Life Quality Index score at 13 weeks and in secondary end points
By Elana Gotkine (HealthDay News) | May 10, 2023
Electromagnetic Field Technology Plus Radiofrequency Cuts Visceral Adipose Tissue
High-intensity focused electromagnetic field technology with radiofrequency reduces VAT at three months; reduction maintained at six months
By Dermsquared Editorial Team | May 10, 2023
Adalimumab Plus Surgery Better for Hidradenitis Suppurativa
Greater reduction seen in International HS Severity Score System and in Dermatology Life Quality Index in combination group
By Dermsquared Editorial Team | May 05, 2023
Convolution Neural Network Aids Diagnosis for Melanocytic Lesions by Dermatologists
The most diagnostic improvement was seen for dermatologists with less dermoscopy experience cooperating with the CNN
By Dermsquared Editorial Team | May 05, 2023
CDC Reports No New Mpox Cases in Over a Week for First Time Since Outbreak Began
Since the outbreak began last May, more than 30,000 people have been infected with the virus and 42 people have died
By Physician's Briefing Staff | May 05, 2023
New Model Helps ID Melanoma Patients With Lymph Node Involvement
Patient-centered methodology-generated probabilities better identify patients eligible for sentinel lymph node biopsy than those generated by conventional logistic regression analysis
By Elana Gotkine (HealthDay News) | May 05, 2023
Nearby Nature Does Not Protect Against Early Childhood Eczema
Exposure to coniferous, mixed forests and agriculture areas associated with elevated eczema risk
By Lori Solomon (HealthDay News) | May 05, 2023
Child With Psoriasis Negatively Impacts Mom's Quality of Life
Positive association seen between mothers' Family Dermatology Life Quality Index scores and children's Psoriasis Area Severity Index scores
By Elana Gotkine (HealthDay News) | April 28, 2023
Good Agreement Found for Clinical, Photograph Assessment of Psoriasis
Intraclass correlation coefficient 0.78 between clinical and photographic Psoriasis Area and Severity Index
By Elana Gotkine (HealthDay News) | April 28, 2023
Anti-PD-1 More Effective With Normal Vitamin D Levels in Melanoma
Definition includes five domains of management of clinical symptoms, psychosocial elements, QoL, treatment, health care team support
By Elana Gotkine (HealthDay News) | April 28, 2023
Chronic Hand Eczema Rapidly Improves With Gusacitinib
Significant reductions seen over placebo for 80 mg gusacitinib in mTLSS, PGA, HECSI as early as week 2
By Dermsquared Editorial Team | April 28, 2023
Validity Demonstrated for Hidradenitis Suppurativa Investigator Global Assessment
Tool has good psychometric properties compared with existing measures
By Dermsquared Editorial Team | April 28, 2023
Is Model With SLN Status Effective in Predicting Melanoma-Specific Death?
Model estimating five-year MSD risk that includes sentinel lymph node status provides greater net benefits across treatment thresholds
By Dermsquared Editorial Team | April 05, 2023
Does Vitamin D Supplementation Impact Psoriasis Severity?
No difference seen in change in PASI score, Physician Global Assessment score, self-administered PASI, Dermatology Life Quality Index
By Dermsquared Editorial Team | April 05, 2023
Risk for Melanoma Reduced for Individuals With Atopy
Fewer cases of melanoma, lower investigator-estimated risk class of skin cancer observed in atopic versus nonatopic individuals
By Elana Gotkine (HealthDay News) | March 31, 2023
AAD: Nemolizumab Beneficial for Patients With Prurigo Nodularis
Improvement seen in primary and key secondary end points, including peak pruritus numerical rating scale, sleep disturbance
By Dermsquared Editorial Team | March 29, 2023
AAD: Long-Term Efficacy Seen for Baricitinib in Alopecia Areata
39.1 percent of baricitinib 4-mg-treated patients with SALT score >20 at week 52 achieved SALT score ≤20 by week 104
By Dermsquared Editorial Team | March 29, 2023
Promising Results Seen for Bimekizumab in Hidradenitis Suppurativa
Significantly higher proportion of hidradenitis suppurativa patients treated with bimekizumab achieved primary end point of HiSCR50
By Elana Gotkine (HealthDay News) | March 29, 2023
Long-Term Improvement Seen With Ruxolitinib in Vitiligo
Improvement in facial/total Vitiligo Area Scoring Index seen with continued treatment from weeks 52 to 104
By Elana Gotkine (HealthDay News) | March 28, 2023
Risk for Skin Cancer Higher for Adults With Atopic Dermatitis
Significantly increased risk seen for adults with moderate-to-severe versus mild atopic dermatitis
By Elana Gotkine (HealthDay News) | March 27, 2023
Topical Lovastatin Aids Disseminated Superficial Actinic Porokeratosis
Disease severity decreased by about 50 percent in the lovastatin-cholesterol and lovastatin-alone treatment groups
By Dermsquared Editorial Team | March 22, 2023
Hispanic Patients More Likely to Have Melanoma Diagnosed at Stage IV
Significant differences seen for insurance status, income, education, Charlson-Deyo score, stage for Hispanic, White patients
By Dermsquared Editorial Team | March 22, 2023
Smoking Independently Tied to Higher Risk for Psoriasis
However, based on genetic analysis, smoking may not be a causal factor of psoriasis
By Lori Solomon (HealthDay News) | March 21, 2023
Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients
No difference seen in keratinocyte cancers or actinic keratoses for organ-transplant recipients receiving oral nicotinamide or placebo
By Elana Gotkine (HealthDay News) | March 17, 2023
No Benefit Seen for Plasmapheresis First After Corticosteroids for SJS/TEN
Medical costs, LOS higher with plasmapheresis first versus intravenous immunoglobulin first for Stevens-Johnson syndrome and toxic epidermal necrolysis
By Dermsquared Editorial Team | March 15, 2023
Can AI Tool Improve Quality of Patient-Submitted Images of Skin Disease?
Patient use of machine learning algorithm led to reduction in number of patients with poor-quality images
By Dermsquared Editorial Team | March 15, 2023
Hair Regrowth Seen in Alopecia With Methotrexate Prednisone
About 31 percent of patients with recalcitrant alopecia areata totalis or universalis had complete hair regrowth
By Elana Gotkine (HealthDay News) | March 15, 2023
Neoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma
Event-free survival longer for those receiving neoadjuvant and adjuvant pembrolizumab versus adjuvant pembrolizumab only
By Physician's Briefing Staff | March 10, 2023
Is Paroxetine Efficacious, Safe for Erythema of Rosacea?
Significantly greater proportion of patients achieved Clinical Erythema Assessment success with paroxetine versus placebo
By Dermsquared Editorial Team | March 08, 2023
Microneedling, 5FU, Excimer Promising for Nonsegmental Vitiligo
Combination of 5FU after microneedling and excimer more suitable for localized, focal vitiligo
By Dermsquared Editorial Team | March 08, 2023
Most Patients Like Having Access to Dermatology Clinic Notes
Concerns were few and included not understanding notes or abbreviations
By Lori Solomon (HealthDay News) | March 08, 2023
Burden of Alopecia Areata Significant in the United States
Standardized prevalence highest in those aged 30 to 39, 40 to 49 years; Asians, Blacks, Hispanic/Latinos have increased prevalence ratios
By Elana Gotkine (HealthDay News) | March 06, 2023
Prevalence of Alopecia Areata Increased From 2016 to 2019 in the United States
Prevalence and incidence higher for females versus males, adults versus children and teens, in Northeast versus other regions
By Dermsquared Editorial Team | March 01, 2023
2005 to 2015 Saw Increase in Prevalence of Total Body Skin Exams
Only race/ethnicity with increase was non-Hispanic Whites; increases seen for those aged 31 to 40, 51 to 64 years
By Dermsquared Editorial Team | March 01, 2023
Psoriasis Tied to Elevated Risk for Celiac Disease
People with psoriasis have double the odds of celiac disease versus people without psoriasis
By Lori Solomon (HealthDay News) | February 28, 2023
AAAAI: Black Children With Eczema More Likely to Have Asthma
Black children with asthma less likely to have seen an allergist, more likely to lack prior inhalant allergy testing
By Elana Gotkine (HealthDay News) | February 27, 2023
Methotrexate Linked to Increased Risk for Skin Cancer
When restricting analysis to patients with psoriasis, methotrexate was only associated with basal cell carcinoma
By Elana Gotkine (HealthDay News) | February 23, 2023
1997 to 2018 Saw Increase in Prevalence of Eczema in Children
Average annual percentage change of prevalence was lower in White versus Black and multiracial children
By Dermsquared Editorial Team | February 22, 2023
Headline from the Week of May 22-28, 2023
By Dermsquared Editorial Team | May 24, 2023
By Dermsquared Editorial Team | May 24, 2023